Tokorozawa, Japan

Sadanori Ogasawara

This inventor holds 2 USPTO granted patents. Top assignee: Mect Corporation. Active years: 1987-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sadanori Ogasawara. Retrieved from https://idiyas.com/inventor/sadanori-ogasawara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1987-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sadanori Ogasawara: Innovator in Medical Solutions

Introduction

Sadanori Ogasawara is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of medical innovations, holding a total of 2 patents. His work focuses on developing solutions that enhance the healing and treatment processes in medical applications.

Latest Patents

Ogasawara's latest patents include a repairing agent for cells and tissues and an expectorant. The repairing agent comprises a compound that serves as an active ingredient, which can include lithium, potassium, sodium, ammonium, or organic ammonium when n is 1, and calcium, barium, or magnesium when n is 2. The expectorant is designed to act on the rheological properties of sputum and promotes ciliary motion, containing N-acetylneuraminic acid or a pharmaceutically active salt thereof.

Career Highlights

Ogasawara is associated with Mect Corporation, where he continues to innovate and develop new medical solutions. His work has been instrumental in advancing treatments that improve patient outcomes.

Collaborations

He has collaborated with notable coworkers, including Masayoshi Ito and Yoshiyasu Shitori, contributing to a dynamic team focused on medical advancements.

Conclusion

Sadanori Ogasawara's contributions to medical innovations through his patents reflect his commitment to improving healthcare solutions. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…